León Xavier, García Jacinto, López Montserrat, Holgado Anna, Llansana Albert, Quer Miquel
Servicio de Otorrinolaringología, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.
Servicio de Otorrinolaringología, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Acta Otorrinolaringol Esp (Engl Ed). 2021 Nov-Dec;72(6):359-369. doi: 10.1016/j.otoeng.2020.08.007.
To analyse the trend in the percentage of patients with squamous cell carcinoma of the head and neck (SCCHN) of female gender over the last decades, and differences in survival according to gender.
Retrospective study of 5828 SCCHN diagnosed during the period 1985-2019. In the survival analysis we only included only patients with more than two years of follow-up.
The proportion of tumours in female patients increased significantly over the study period. There was greater increase of tumours located in the oral cavity, oropharynx and larynx in the percentage of female patients. When considering the total number of patients, there were no significant differences in disease-specific survival according to gender. We observed a variable behaviour of disease-specific survival according to gender depending on the primary location of the tumour. For tumours of the larynx and oropharynx the female patients had a disease-specific survival significantly higher than that of men, while for tumours of the oral cavity, the female patients had a significant reduction of disease-specific survival.
In our setting, the percentage of female patients with HNSCC has been increasing steadily over recent decades. There were differences in disease-specific survival according to gender depending on the location of the primary tumour.
分析过去几十年中女性头颈部鳞状细胞癌(SCCHN)患者的百分比趋势,以及根据性别划分的生存差异。
对1985年至2019年期间诊断出的5828例SCCHN进行回顾性研究。在生存分析中,我们仅纳入了随访时间超过两年的患者。
在研究期间,女性患者肿瘤的比例显著增加。女性患者中位于口腔、口咽和喉的肿瘤百分比增加幅度更大。考虑患者总数时,根据性别划分的疾病特异性生存率没有显著差异。根据肿瘤的原发部位,我们观察到根据性别划分的疾病特异性生存率存在不同表现。对于喉和口咽肿瘤,女性患者的疾病特异性生存率显著高于男性,而对于口腔肿瘤,女性患者的疾病特异性生存率显著降低。
在我们的研究环境中,近几十年来女性HNSCC患者的百分比一直在稳步上升。根据性别划分的疾病特异性生存率因原发肿瘤的位置而异。